AnaMar AB: Clinical Trials

3 trials sponsored by AnaMar AB, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Terminated 1
Phase 21Completed 1

Follow AnaMar AB: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety, Tolerability and Pharmacokinetics of AM1476 in Healthy Subjects
AM1476, Placebo - Safety, Tolerability
Phase 1CompletedAnaMar AB972020-12-162024-08-02
A Study to Assess the Safety, Tolerability, PK and PD of AM1030-CREAM in Patients With Atopic Dermatitis
AM1030-CREAM or placebo - Atopic Dermatitis
Phase 1 / Phase 2CompletedAnaMar AB362014-11-012015-12-11
AMAP102 - Safety, Tolerability and Pharmacokinetics in Healthy Subjects
AMAP102 - Healthy Volunteers
Phase 1TerminatedAnaMar AB402009-04-012009-10-15

Conditions studied

Dermatitis, Atopic (1)

Countries

United Kingdom (3)

Top investigators

Dr Joseph Chiesa, MD FFPM FICR CSci (1)  ·  Jim Bush (1)

NIH funding

2008 (1), 2014 (1)